All Stories

  1. CD20 monoclonal antibodies for the treatment of multiple sclerosis: up-to-date

    Article • Expert Opinion on Biological Therapy, May 2019, Taylor & Francis

    Prof. Bernhard Hemmer

  2. Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials

    Article • Multiple Sclerosis Journal, March 2018, SAGE Publications

    Prof. Bernhard Hemmer

  3. From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis

    Article • Current Neuropharmacology, July 2017, Bentham Science Publishers

    Prof. Bernhard Hemmer

  4. Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation

    Article • Science Advances, June 2016, American Association for the Advancement of Science

    Prof. Bernhard Hemmer